NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | de5e7c85-5bf5-5b5f-e053-2995a90a1fba | 2026-06-01 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 6eab1c0a-9328-42a6-8eae-d4e105c54716 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 85494404-484c-45a1-8487-f9eb2a76490d | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ENALAPRIL MALEATE | ENALAPRIL MALEATE | Bryant Ranch Prepack | c1e4cd79-ece5-432c-bd3a-ed4633ccec70 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 52b90789-2902-3ab9-e063-6394a90a5abb | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Calamine | CALAMINE AND ZINC OXIDE | Pharma Nobis, LLC | fbcfa541-beda-06de-e053-6294a90a9298 | 2026-05-26 | Warnings | 1K09F3G675 |
| Humco Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc. | aeaa34f6-216d-49f3-8393-c7bda96a3e32 | 2026-05-26 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | 8MDF5V39QO |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 5956a107-0f7b-49e7-b9c9-36790349b06e | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals, Inc. | 5aa18b0b-4688-493a-a5ae-cb056ea6c0e3 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 9207c3bc-e12e-4017-8b85-0f928e744f64 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | fc4d7d0e-78a6-4d7e-ba53-aeeb008aa2dc | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals Inc | 52332190-2a12-d205-e063-6394a90ab7c5 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 77e71a2e-8370-4f7a-a5e4-93d86bd37dad | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 544b75eb-55f1-4164-9b83-39f6bc5fb479 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | c5258ea3-3aac-48fd-be5a-f8e4a47ca94a | 2026-05-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| WHITENING SUNSCREENANTI WRINKLE | WHITENING SUNSCREENANTI WRINKLE | Shantou Oushiya Biotechnology Co.,Ltd | 524384e9-b3f8-4c13-e063-6394a90a8973 | 2026-05-20 | Warnings | 059QF0KO0R |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | a013211e-b8f8-426d-8e55-e86193f0634e | 2026-05-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f22a10a2-8f84-4060-9143-427237c51280 | 2026-05-19 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.